×

Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system

Improved results of LINE-1 methylation analysis in formalin-fixed, paraffin-embedded tissues with the application of a heating step during the DNA extraction process

Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis

Downregulation of acetyl-CoA synthetase 2 is a metabolic hallmark of tumor progression and aggressiveness in colorectal carcinoma

Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers

Epigenetic alterations in colorectal cancer: the CpG island methylator phenotype

Visceral obesity predicts significant fibrosis in patients with nonalcoholic fatty liver disease

Changes in non-invasive liver fibrosis indices and spleen size during chemotherapy: potential marker for oxaliplatin-induced sinusoidal obstruction syndrome

The relationship between the methylenetetrahydrofolate reductase genotypes and the methylation status of the CpG island loci, LINE-1 and Alu in prostate adenocarcinoma

Toll-like receptor 2 mediates a cutaneous reaction induced by repetitive ultraviolet B irradiation in C57/BL6 mice in vivo

Molecular subtypes of colorectal cancer and their clinicopathologic features, with an emphasis on the serrated neoplasia pathway

Matricellular protein periostin mediates intestinal inflammation through the activation of nuclear factor κB signaling

Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?

Prospective comparison of noninvasive fibrosis assessment to predict advanced fibrosis or cirrhosis in Asian patients with hepatitis C

Annexin A10 expression in colorectal cancers with emphasis on the serrated neoplasia pathway

Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma

Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation

CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels

Genomic hypomethylation and CpG island hypermethylation in prostatic intraepithelial neoplasm

Differential clinicopathological features in microsatellite instability-positive colorectal cancers depending on CIMP status

Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location

Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway

Clinicopathologic, molecular, and prognostic implications of the loss of EPCAM expression in colorectal carcinoma

Gastric-type expression signature in serrated pathway-associated colorectal tumors

Pathologic factors associated with prognosis after adjuvant chemotherapy in stage II/III microsatellite-unstable colorectal cancers

Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer

Comparative validation of assessment criteria for Crohn-like lymphoid reaction in colorectral carcinoma

Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability

Annexin A10 expression in microsatellite-unstable colorectal cancers: is it specific to sporadic tumors?

Differential features of microsatellite-unstable colorectal carcinomas depending on EPCAM expression status

Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer

Expression status of wild-type HSP110 correlates with HSP110 T17 deletion size and patient prognosis in microsatellite-unstable colorectal cancer

Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype and adverse prognosis in microsatellite-unstable colorectal cancer

Subsets of microsatellite-unstable colorectal cancers exhibit discordance between the CpG island methylator phenotype and MLH1 methylation status

DNA methylation changes in ex-adenoma carcinoma of the large intestine

Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers